lidocaine has been researched along with Premenstrual Syndrome in 1 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The mechanism of many neuropsychiatric disorders remains unknown, but the ineffectiveness of the sodium channel blocker lidocaine has been suggested to be a biomarker for Attention Deficit Hyperactivity Disorder (ADHD) and a severe form of Premenstrual Syndrome (PMS) that is considered psychiatric." | 5.51 | Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target. ( Axelrod, I; Badner, V; Chow, H; Diaz, J; Feldman, LK; Gleeson, J; Liu, C; Mezhebovsky, I; Mintz, M; Mintz, P; Saraghi, M; Segal, MM; Smith, C; Zurakowski, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mintz, M | 1 |
| Badner, V | 1 |
| Feldman, LK | 1 |
| Mintz, P | 1 |
| Saraghi, M | 1 |
| Diaz, J | 1 |
| Mezhebovsky, I | 1 |
| Axelrod, I | 1 |
| Gleeson, J | 1 |
| Liu, C | 1 |
| Smith, C | 1 |
| Chow, H | 1 |
| Zurakowski, D | 1 |
| Segal, MM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevalence of Lidocaine Ineffectiveness in Those With Hard-to-treat ADHD[NCT04167189] | Early Phase 1 | 28 participants (Actual) | Interventional | 2018-01-20 | Completed | ||
| Reliability Testing of a Non-invasive, Pain-free, Taste-based Assessment Approach to Lidocaine Effectiveness[NCT03680885] | Early Phase 1 | 20 participants (Actual) | Interventional | 2019-08-01 | Completed | ||
| Assessing the Frequency of Lidocaine Ineffectiveness in the General Population vs. Males With ADHD, and Females With ADHD, With or Without PMS[NCT03676725] | Early Phase 1 | 90 participants (Actual) | Interventional | 2019-08-14 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for lidocaine and Premenstrual Syndrome
| Article | Year |
|---|---|
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target.
Topics: Double-Blind Method; Female; Humans; Lidocaine; Personality; Premenstrual Dysphoric Disorder; Premen | 2022 |
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target.
Topics: Double-Blind Method; Female; Humans; Lidocaine; Personality; Premenstrual Dysphoric Disorder; Premen | 2022 |
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target.
Topics: Double-Blind Method; Female; Humans; Lidocaine; Personality; Premenstrual Dysphoric Disorder; Premen | 2022 |
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target.
Topics: Double-Blind Method; Female; Humans; Lidocaine; Personality; Premenstrual Dysphoric Disorder; Premen | 2022 |
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target.
Topics: Double-Blind Method; Female; Humans; Lidocaine; Personality; Premenstrual Dysphoric Disorder; Premen | 2022 |
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target.
Topics: Double-Blind Method; Female; Humans; Lidocaine; Personality; Premenstrual Dysphoric Disorder; Premen | 2022 |
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target.
Topics: Double-Blind Method; Female; Humans; Lidocaine; Personality; Premenstrual Dysphoric Disorder; Premen | 2022 |
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target.
Topics: Double-Blind Method; Female; Humans; Lidocaine; Personality; Premenstrual Dysphoric Disorder; Premen | 2022 |
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target.
Topics: Double-Blind Method; Female; Humans; Lidocaine; Personality; Premenstrual Dysphoric Disorder; Premen | 2022 |